| - GRCh37:
- Chr14:35873823
- GRCh38:
- Chr14:35404617
| NFKBIA | E10* | Ectodermal dysplasia and immunodeficiency 2 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr14:35182071-35873850
| BAZ1A, CFL2, FAM177A1, NFKBIA, PPP2R3C, PRORP, PSMA6, SRP54 | | not provided, Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872048
- GRCh38:
- Chr14:35402842
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872922
- GRCh38:
- Chr14:35403716
| NFKBIA | L104F | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Jun 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872484
- GRCh38:
- Chr14:35403278
| NFKBIA | R140P | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Sep 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872378
- GRCh38:
- Chr14:35403172
| NFKBIA | I175M | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872032
- GRCh38:
- Chr14:35402826
| NFKBIA | G194D | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873807
- GRCh38:
- Chr14:35404601
| NFKBIA | G15D | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871680
- GRCh38:
- Chr14:35402474
| NFKBIA | N276D | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872345
- GRCh38:
- Chr14:35403139
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872892
- GRCh38:
- Chr14:35403686
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873832
- GRCh38:
- Chr14:35404626
| NFKBIA | R7C | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Oct 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871883
- GRCh38:
- Chr14:35402677
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871962
- GRCh38:
- Chr14:35402756
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873824
- GRCh38:
- Chr14:35404618
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871973
- GRCh38:
- Chr14:35402767
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871602
- GRCh38:
- Chr14:35402396
| NFKBIA | E302K | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871658
- GRCh38:
- Chr14:35402452
| NFKBIA | S283N | Inborn genetic diseases, Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Sep 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:35872394
- GRCh38:
- Chr14:35403188
| NFKBIA | P170L | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871754
- GRCh38:
- Chr14:35402548
| NFKBIA | Y251C | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Sep 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872425
- GRCh38:
- Chr14:35403219
| NFKBIA | V160L | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873619
- GRCh38:
- Chr14:35404413
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871756
- GRCh38:
- Chr14:35402550
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Mar 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872889
- GRCh38:
- Chr14:35403683
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872430
- GRCh38:
- Chr14:35403224
| NFKBIA | A158V | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (May 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871818
- GRCh38:
- Chr14:35402612
| NFKBIA | P230A | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872021
- GRCh38:
- Chr14:35402815
| NFKBIA | I198V | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Mar 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872493
- GRCh38:
- Chr14:35403287
| NFKBIA | P137fs | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Feb 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872367
- GRCh38:
- Chr14:35403161
| NFKBIA | T179I | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Jan 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872475
- GRCh38:
- Chr14:35403269
| NFKBIA | R143Q | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872397
- GRCh38:
- Chr14:35403191
| NFKBIA | T169I | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871272
- GRCh38:
- Chr14:35402066
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Dec 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871644
- GRCh38:
- Chr14:35402438
| NFKBIA | S288G | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873700
- GRCh38:
- Chr14:35404494
| NFKBIA | E51K | Ectodermal dysplasia and immunodeficiency 2 | Benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873607
- GRCh38:
- Chr14:35404401
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Aug 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871261
- GRCh38:
- Chr14:35402055
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872487
- GRCh38:
- Chr14:35403281
| NFKBIA | L139R | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873833
- GRCh38:
- Chr14:35404627
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872950
- GRCh38:
- Chr14:35403744
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873801
- GRCh38:
- Chr14:35404595
| NFKBIA | R17H | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872394
- GRCh38:
- Chr14:35403188
| NFKBIA | P170R | Ectodermal dysplasia and immunodeficiency 2 | Benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871765
- GRCh38:
- Chr14:35402559
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872487
- GRCh38:
- Chr14:35403281
| NFKBIA | L139P | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871645
- GRCh38:
- Chr14:35402439
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872371
- GRCh38:
- Chr14:35403165
| NFKBIA | A178T | Ectodermal dysplasia and immunodeficiency 2, Inborn genetic diseases | Uncertain significance (Sep 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:35872041
- GRCh38:
- Chr14:35402835
| NFKBIA | S191C | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871256
- GRCh38:
- Chr14:35402050
| NFKBIA | D306G | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873733
- GRCh38:
- Chr14:35404527
| NFKBIA | E40K | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873805
- GRCh38:
- Chr14:35404599
| NFKBIA | P16A | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871664
- GRCh38:
- Chr14:35402458
| NFKBIA | P281L | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Jul 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872416
- GRCh38:
- Chr14:35403210
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jan 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871610-35871621
- GRCh38:
- Chr14:35402404-35402415
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871618
- GRCh38:
- Chr14:35402412
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872338
- GRCh38:
- Chr14:35403132
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872935
- GRCh38:
- Chr14:35403729
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872399
- GRCh38:
- Chr14:35403193
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872462
- GRCh38:
- Chr14:35403256
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871957
- GRCh38:
- Chr14:35402751
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872082
- GRCh38:
- Chr14:35402876
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871640
- GRCh38:
- Chr14:35402434
| NFKBIA | Y289C | Ectodermal dysplasia and immunodeficiency 2 | Benign (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871986
- GRCh38:
- Chr14:35402780
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871837
- GRCh38:
- Chr14:35402631
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871581
- GRCh38:
- Chr14:35402375
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (May 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872426
- GRCh38:
- Chr14:35403220
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872876
- GRCh38:
- Chr14:35403670
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Benign (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872967
- GRCh38:
- Chr14:35403761
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Mar 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871225
- GRCh38:
- Chr14:35402019
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872581
- GRCh38:
- Chr14:35403375
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873012
- GRCh38:
- Chr14:35403806
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872904
- GRCh38:
- Chr14:35403698
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873806
- GRCh38:
- Chr14:35404600
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Aug 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872877
- GRCh38:
- Chr14:35403671
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jun 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871584
- GRCh38:
- Chr14:35402378
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jun 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871280-35871281
- GRCh38:
- Chr14:35402074-35402075
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872500
- GRCh38:
- Chr14:35403294
| NFKBIA | C135G | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872880
- GRCh38:
- Chr14:35403674
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871958
- GRCh38:
- Chr14:35402752
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Sep 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:35872438
- GRCh38:
- Chr14:35403232
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Jul 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872070
- GRCh38:
- Chr14:35402864
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872912
- GRCh38:
- Chr14:35403706
| NFKBIA | Q107R | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Oct 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872976
- GRCh38:
- Chr14:35403770
| NFKBIA | E86K | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Nov 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871229
- GRCh38:
- Chr14:35402023
| NFKBIA | L315R | Inborn genetic diseases, Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Nov 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:35871745
- GRCh38:
- Chr14:35402539
| NFKBIA | Y254C | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Jul 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872945
- GRCh38:
- Chr14:35403739
| NFKBIA | Q96R | not provided, Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Dec 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:35871625
- GRCh38:
- Chr14:35402419
| NFKBIA | E294G | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871722
- GRCh38:
- Chr14:35402516
| NFKBIA | S262G | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873774
- GRCh38:
- Chr14:35404568
| NFKBIA | L26R | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872044
- GRCh38:
- Chr14:35402838
| NFKBIA | A190V | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Feb 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872962
- GRCh38:
- Chr14:35403756
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871619
- GRCh38:
- Chr14:35402413
| NFKBIA | T296M | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:35872992
- GRCh38:
- Chr14:35403786
| NFKBIA | | Ectodermal dysplasia and immunodeficiency 2 | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873796
- GRCh38:
- Chr14:35404590
| NFKBIA | G19R | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872907
- GRCh38:
- Chr14:35403701
| NFKBIA | N109H | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35871764
- GRCh38:
- Chr14:35402558
| NFKBIA | Y248H | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872036
- GRCh38:
- Chr14:35402830
| NFKBIA | H193N | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872563
- GRCh38:
- Chr14:35403357
| NFKBIA | P114A | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Oct 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873785-35873787
- GRCh38:
- Chr14:35404579-35404581
| NFKBIA | K22del | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873658
- GRCh38:
- Chr14:35404452
| NFKBIA | P65A | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35873840
- GRCh38:
- Chr14:35404634
| NFKBIA | A4V | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:35872948
- GRCh38:
- Chr14:35403742
| NFKBIA | R95P | Ectodermal dysplasia and immunodeficiency 2 | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |